The data displays the sales share of the leading analgesic-internal tablet brands in the U.S. in 2016. In that year, private label analgesic-internal tablet prands had 36% of total dollar sales in the U.S.
Private label | 36 |
Advil | 14.8 |
Aleve | 10.5 |
Tylenol | 8 |
Bayer | 6.4 |
Advil PM | 2.7 |
Excedrin Migraine | 2.6 |
Excedrin | 2.2 |
Motrin IB | 2.1 |
Aleve PM | 1.5 |